Congressional Hearing on Federal Cancer Research Funding
January 1, 2018
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This hearing serves as a public forum for lawmakers to evaluate whether current federal funding levels and research strategies are sufficient to address the daily mortality rate of 1,500 cancer-related deaths in the United States.
Potentially affected actors named in the source documents. Mention is not a position.
Cancer patients and their families
They are directly impacted by the outcomes of cancer research and the availability of federal funding for treatment and prevention.
Medical research institutions
These organizations rely on federal grants and funding to conduct clinical trials and laboratory research.
Last recorded activity January 1, 2018.
Next step not available in the current record.
Summary
Key Facts
- The hearing took place on March 29, 2017, in the Rayburn House Office Building.
- Approximately 1,500 people die from cancer in the United States every day.
- Chairman Jason Chaffetz publicly criticized the Trump administration's budget proposal regarding cancer research funding, labeling it 'pathetic and inadequate'.
- The committee heard testimony from four expert witnesses representing cancer research foundations and academic medical centers.
- The hearing focused on the intersection of federal funding, research coordination, and medical innovation.
Why It Matters
This hearing serves as a public forum for lawmakers to evaluate whether current federal funding levels and research strategies are sufficient to address the daily mortality rate of 1,500 cancer-related deaths in the United States.
Frequently Asked Questions
What was the purpose of this hearing?
Who testified at the hearing?
News Coverage
Sponsors
Show 2 more sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Bipartisan Tension on Research Funding
The hearing highlights a rare moment where a Republican Chairman publicly broke with his own party's administration regarding the adequacy of proposed research budget cuts.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy60Intensity of disagreement among stakeholders
- Entertainment20Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools